Although FTO is an established obesity-susceptibility locus, it remains unknown whether it influences weight change in adult life and whether diet attenuates this association. Therefore, we investigated the association of FTO-rs9939609 with changes in weight and waist circumference (WC) during 6.8 years follow-up in a large-scale prospective study and examined whether these associations were modified by dietary energy percentage from fat, protein, carbohydrate, or glycemic index (GI). This study comprised data from five countries of European Prospective Investigation into Cancer and Nutrition (EPIC) and was designed as a case-cohort study for weight gain. Analyses included 11,091 individuals, of whom 5,584 were cases (age (SD), 47.6 (7.5) years), defined as those with the greatest unexplained annual weight gain during follow-up and 5,507 were noncases (48.0 (7.3) years), who were compared in our case-noncase (CNC) analyses. Furthermore, 6,566 individuals (47.9 (7.3) years) selected from the total sample (all noncases and 1,059 cases) formed the random subcohort (RSC), used for continuous trait analyses. Interactions were tested by including interaction terms in the models. In the RSC-analyses, FTO-rs9939609 was associated with BMI (β (SE), 0.17 (0.08) kg·m −2 /allele; P = 0.034) and WC (0.47 (0.21) cm/allele; P = 0.026) at baseline, but not with weight change (5.55 (12.5) g·year -1 /allele; P = 0.66) during follow up. In the CNC-analysis, FTO-rs9939609 was associated with increased risk of being a weight-gainer (OR: 1.1; P = 0.045). We observed no interaction between FTO-rs9939609 and dietary fat, protein and carbohydrate, and GI on BMI and WC at baseline or on change in weight and WC. FTO-rs9939609 is associated with BMI and WC at baseline, but association with weight gain is weak and only observed for extreme gain. Dietary factors did not influence the associations.
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In the present study, we examine the association of the FTOrs9939609 variant with BMI and WC at baseline and also change in weight and WC over an average period of 6.8 (SD 2.5) years. We furthermore test whether associations are modified by fat E%, carbohydrate E%, protein E%, and glycemic index (GI). We tested our hypotheses in a large prospective population which comprises data from five European countries (n = 11,091) participating in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Methods and Procedures study population
The study is part of the DiOGenes project (http://www.diogenes-eu. org/), a multidisciplinary European programme that focuses on dietary components and genetic and behavioural factors in the prevention of weight gain (19) . The current analyses include data from five countries participating in the EPIC (19); i.e., Denmark (Aarhus and Copenhagen), Germany (Potsdam), United Kingdom (Norfolk), Italy (Florence), and the Netherlands (Doetinchem, Amsterdam, and Maastricht) (see Supplementary Table S1 online). Individuals younger than 60 years at baseline and younger than 65 years at follow-up, with stable smoking habits, without cancer, cardiovascular disease, or diabetes at baseline and at follow-up, and with an annual weight change not >5 kg/year were eligible for the current study. In total, 50,293 men and women (22, 844 participants from Denmark, 6,446 from the UK, 8,813 from Germany, 6,576 from the Netherlands, and 5,614 from Italy) for whom baseline information for BMI, weight, height, and diet, and follow-up information on weight were available, were eligible for inclusion in our analyses (see Supplementary Table S2 online).
study design
The study design has been described in detail before (20) . In brief, cases were defined as those individuals who had experienced the greatest degree of unexplained weight gain and were identified by using the residuals from a regression model of annual weight change on baseline values of age, weight, height, and smoking status (current/former/ nonsmokers) and follow-up time. In each of the countries except Italy, cases were identified as the 600 men and 600 women with the largest unexplained weight gain. As men were underrepresented (27%) in the Italian cohort, 300 men and 900 women were selected to represent the sex distribution of this cohort.
Noncases together with some cases formed the random subcohort (RSC). The random sample subcohort comprised a random sample of individuals that was drawn in such a way that the total number of noncases (controls) in each centre equaled the number of cases (n = 1,200) (see Supplementary Table S2 online). To obtain in total 6,000 noncases, over sampling was performed in all centers except Denmark, where overlap between cases and subcohort was negligible (n = 79). In total, 7,063 participants were included in the RSC, of which 5,930 were noncases.
Of the 11,930 participants, 11,257 had DNA available for genotyping. Of these, genotyping failed for 143 samples and for 23 individuals, nutritional data was not available. Hence, our analyses included 11,091 individuals of whom, 5,584 were cases (weight-gainers) and 5,507 were noncases. For the case-noncase (CNC) analysis, 5,584 cases and 5,507 noncases were used. The RSC (n = 6,566) consisted of the 5,507 noncases (controls) and 1,059 cases.
anthropometry, dietary, and other measurements Details of the anthropometric measurements have been described previously (21) . In brief, at baseline all participants were measured for weight, height, and waist circumference (WC) using standard study protocols. At follow-up, participants in Norfolk (UK) and Doetinchem (NL) were measured by trained technicians, whereas participants of the other cohorts measured their weight and WC at home according to the guidance provided. The mean follow-up period was 6.8 ± 2.5 (mean ± SD) years.
Information on lifestyle was collected via self-administered questionnaires at baseline. Validated country-specific Food Frequency Questionnaires were used to collect dietary information at baseline (22) . Energy and nutrient intake were calculated using country-specific food composition tables and subsequently calibrated using 24-h recall data collected from a random sample of all EPIC participants (23) . Energy and nutrient intake from 24-h recalls were calculated based on the standardized European Nutrient DataBase (24) . The values of absolute intakes of fat, protein, and carbohydrate are transformed to energy-form by multiplying with macronutrient-specific factor, dividing by total energy, and finally multiplying by 100 in order to get values to percentage (0-100) form. This was used for calculating fat E%, protein E%, and carbohydrate E%. A specifically developed GI database was used to calculate dietary GI; the methodologies for their calculation have been described in detail elsewhere (25, 26) . dna extraction and genotyping Genomic DNA was extracted from the buffy coats with a salting out method for all participants except for samples from the UK for which whole-genome amplified DNA was used. The FTO variant (rs9939609) was genotyped using the Illumina Beadstation Genotyping System. Researchers and laboratory personnel were blinded to case status and phenotypic data of the samples. The concordance rate and reproducibility were 100% and genotyping call rate was >98%. Genotype distribution in the RSC was in accordance with Hardy-Weinberg equilibrium in each of the cohorts (see Supplementary Table S3 online) .
statistical analysis
The association between the FTO-rs9939609 variant and continuous traits (i.e., baseline BMI, baseline WC, weight change and change in WC) was examined in the RSC only, using linear regression analyses. The association between rs9939609 and the risk of being a case (weight gainer) was tested using logistic regression comparing cases versus noncases. All association analyses assumed an additive effect of the minor allele and were adjusted for the baseline values of age, weight, and sex. The association analyses for weight gain were adjusted for age, sex, baseline weight and height. Weight gain was expressed in g/year.
Interactions between the SNP and the dietary factors (fat E%, carbohydrate E%, protein E%, and GI) were tested by adding the interaction terms in the regression models. We also tested whether association and interaction were different across age and between men and women by including the respective interaction terms in the models.
As the genotype distribution of the variant rs9939609 (P = 0.012) (see Supplementary Table S3 online) and some phenotypic characteristics differed across the five countries, analyses were first conducted in each study center separately and subsequently meta-analyzed using a random effects model. This approach accounts for the possible heterogeneity across study centers and results in an overall (weighted) estimate. Heterogeneity was tested using the Cochran Q-test and I 2 . Statistical analysis was conducted using SAS 9.1 for windows (SAS Institute, Cary, NC) and STATA 9.2 for Windows (StataCorp LP, College Station, TX). Power calculations were performed using Quanto v1.1.1 (http://hydra.usc.edu/gxe). The statistical power to detect an effect size of 0.36 kg/m 2 as reported by Willer et al. (4) at a significance level of 5% was 99.99%. At 80% power, we were able to detect an effect size of at least 0.18 kg/m 2 for a minor allele frequency of 0.41 and a sample size of 6,566 individuals. For gene-diet interactions, the least detectable effect sizes for annual weight gain and CNC status corresponding to 80% power and significance level 0.05 are 6.2 g/year and 1.012 odds per gene-diet unit respectively for carbohydrates (carbohydrates%), 7.2 g/year, and 1.014 odds per gene-diet unit respectively for fat (fat%), 15.9 g/year, and 1.031 odds per gene-diet unit respectively for protein (protein%) and 11.7 g/ year and 1.023 odds per gene-diet unit respectively for GI (GI-unit The FTO-rs9939609 A-allele was associated with higher BMI (β (SE), 0.17 (0.08) kg·m -2 /allele; P = 0.034) (Figure 1 ) and WC (β (SE), 0.47 (0.21) cm/allele; P = 0.026) in the RSC. Heterogeneity across the study centres was low to modest with effect sizes ranging from -0.08 kg·m The CNC comparison showed that the rs9939609 A-allele was associated with a 1.06-fold increased odds of being a weightgainer (95% CI: 1.00-1.11; P = 0.045) (Figure 3) . The odds ratios across the study centres ranged from 1.01 (in Germany and Denmark) to 1.18 (in The Netherlands-Doetinchem) for weight change (heterogeneity, I 2 = 0 %). We observed no interactions between the rs9939609 variant and fat E%, protein E%, carbohydrate E%, or GI on any of BMI, WC, changes in weight or WC, and on risk of being a case (Table 1) . Furthermore, there was no evidence for interaction of the variant with sex and age (sex: P interaction = 0.65; age: P interaction = 0.40) on BMI and WC at baseline and also change in weight and WC.
dIscussIon
In this prospective study of 11,091 adults of five Europeans countries, we confirmed association of the FTO-rs9939609 variant with BMI and WC at baseline. However, no associations between this FTO variant and changes in weight or WC during 6.8 years of follow-up in adult life were observed. Furthermore, fat E%, carbohydrate E%, protein E%, and GI did not affect the associations of the FTO variant with baseline BMI, WC or with changes in weight or WC.
The overall effect of rs9939609 variant on BMI and WC is comparatively smaller in our study than the effect sizes shown in other studies, where each FTO risk allele has been shown to increase BMI by ~0.40-0.66 kg·m -2 (4) and WC by ~1.0-2.4 cm (27). When we stratified by study centre, the effect sizes in the present study ranged from -0.08 kg·m is not necessarily affecting the chances of finding interactions between the gene variant and dietary factors. Furthermore, we observed no association between the FTO variant and change in weight or in WC. However, we found a trend for the rs9939609 A-allele to be associated with 1.06-fold increased odds of being a weight-gainer (P = 0.045), which suggests that FTO's effect on weight gain is only observed in extreme weight-gainers, at least in adults. Two recent studies showed that the FTO locus is associated with weight gain during childhood and adolescence, while the effect attenuates during adult life (28, 29) . A case-cohort study in 1,629 Danish men, representing a broad range of BMI, showed that the AA genotype of the FTO variant, rs9939609, was significantly associated with weight gain from birth to the age of 7 years (P = 0.001) but was not associated with further weight gain during childhood and adolescence (28) . A study in 1,240 men and 1,239 women from the MRC National Survey of Health and Development showed that the association between FTO variant, rs9939609, and BMI strengthened during childhood and adolescence, reached a peak strength at age 20 years, and then weakened during adulthood (29) . Furthermore, two studies (18, 30) , one in 1,275 Dutch adolescents and the other in 1,592 Europeans and African-Americans, failed to observe the changes in effect of the variant on adiposity measures across childhood and adolescence. These studies suggest that the difference in BMI and body weight between the three genotypes are established early in life and subsequently track into adulthood, which is consistent with our observations of a somewhat weaker association. A few studies have examined the interaction between the FTO variant and dietary intake on obesity traits. A study in 204 German individuals found that the FTO-rs8050136 (r 2 = 1.0, with the SNP rs9939609) was associated with BMI at baseline (P < 0.0001), but not with change in body weight after a 9-month lifestyle (exercise and dietary intervention) intervention programme (P = 0.95 for intervention vs. genotype effect) (31) . Furthermore, a study in 776 individuals with a high cardiovascular risk observed no significant interaction between the nutritional intervention (followed-up for 3 years) and the FTO SNP rs9939609 on changes in the body weight (32) . However, a cross-sectional study in 4,839 individuals from the population-based Malmö Diet and Cancer study (33) showed significant interactions between the FTO SNP rs9939609 and fat (P = 0.04) and carbohydrate (P = 0.001) intakes on BMI. Also, a recent study in 21,675 healthy Caucasian women showed that lifestyle factors modified the genetic risk of FTO on obesity phenotypes among those who were both inactive and had high intake of calories (34) . The lack of interaction in some of the studies could be due to the small sample size (n < 2,500) and short follow-up periods or inaccurate measurement of dietary information, which might reduce the statistical power to identify interactions. Despite the fact that our study is large and has sufficient power to identify small changes, we did not observe interaction between the FTO variant and fat E%, protein E%, carbohydrate E%, and GI on weight change. While previous studies found that the BMI-increasing effect is modified by physical activity (15, 16, 27) , our study suggests that the composition of the food with regard to fat, protein, carbohydrate and GI does not have this effect. Our observations and those of others suggest that living a healthy lifestyle in general is not sufficient to attenuate the effect, but that the attenuation may be specific to physical activity.
A few studies have examined the influence of dietary factors on FTO gene function at the molecular level. The FTO variant rs8050136 (r 2 = 1.0, with the SNP rs9939609) affects binding affinity of the transcription factor, CUX1, which regulates the FTO gene expression (35) . Reduced expression of Fto was shown to affect leptin signaling in vitro. Studies have also shown that excess fat intake (36) and high-protein diets (37) may influence the serum levels of leptin. It may be hypothesized that excess fat and protein intake might have an effect on the binding affinity of CUX1, which can affect FTO expression and, in turn, affect leptin signaling leading to obesity. However, further studies are required to prove this hypothesis.
In summary, our study confirms that genetic variation in FTO is associated with the general level of fatness as assessed by BMI and WC. However, the evidence of association with weight change during adult life is weak and association was only observed for more extreme weight gain. The results suggest that weight changes in adults are not influenced by interactions between the FTO polymorphism and macronutrient composition of the diet. 
